Skip to main content
. 2022 Dec 19;9(12):467. doi: 10.3390/jcdd9120467

Table 1.

Baseline characteristics.

Parameter n = 215
Age (years) 64.2 ± 13.3
Male 160 (74.4)
BMI 28.2 ± 11.9
Logistic EuroSCORE II 15.6 ± 10.9
Coronary artery disease 50 (23.2)
Peripheral occlusive disease 28 (13.0)
Diabetes mellitus 41 (19.1)
Malignancies 31 (14.4)
Serum kreatinin (mg/dL) 1.6 ± 2.2
Chronic hemodialysis 18 (8.4)
Immunosuppression 15 (7.0)
i.v. drug abuse 9 (4.2)
NYHA functional class III/IV 104 (48.4)
Native valves 160 (74.4)
IE affected valves
Aortic valve only 114 (52.3)
Mitral valve only 80 (37.2)
Combined aortic and mitral 21 (9.8)
Regurgitation degree II/III
Aortic valve 78 (57.7)
Mitral valve 68 (67.3)
LVEF > 50% 142 (66.0)
LVEF < 30% 19 (8.8)
Embolism 151 (70.2)
Cerebral 77 (35.8)
Renal 38 (17.7)
Spleen 21 (9.8)
Eyes 13 (6.0)
Other 10 (4.6)
Fever 185 (86.0)
WBC (1/nL) 11.4 ± 5.5
CRP (mg/L) 90.1 ± 77.9
PCT (ng/mL) 4.3 ± 13.3
Vegetation size (mm) 14.8 ± 5.8
NT-proBNP (pg/mL) 4398 (1310, 11,830)
Log(NT-proBNP) 3.62 ± 0.70

Values are n (%) or mean ± SD, except for NT-proBNP with median (IQR). BMI = body mass index; CRP = C-reactive protein; IE = infective endocarditis; LVEF = left ventricular ejection fraction; NT-proBNP = N-terminal prohormone of B-type natriuretic peptide; NYHA = New York Heart Association; PCT = procalcitonin; WBC = white blood cell count.